Active filters
Category
-
Antibodies
- Primary Antibodies
Applications
- WB
Families
- Nuclear Hormone Receptor
Filter by
Target Symbol
- PROGESTERONE RECEPTOR (169)
- GLUCOCORTICOID RECEPTOR (64)
- ESTROGEN RECEPTOR 1 (53)
- ESTROGEN RELATED RECEPTOR ALPHA (53)
- NR2E3 (53)
- NR2C2 (51)
- NR2C1 (47)
- RETINOIC ACID RECEPTOR ALPHA (47)
- P23 (46)
- NOR1 (42)
- PPAR ALPHA (42)
- THYROID HORMONE RECEPTOR ALPHA (42)
- CONSTITUTIVE ANDROSTANE RECEPTOR (41)
- ANDROGEN RECEPTOR (39)
- HNF 4 ALPHA (38)
- ESTROGEN RELATED RECEPTOR GAMMA (34)
- ESTROGEN RELATED RECEPTOR BETA (33)
- ROR BETA (32)
- ESTROGEN RECEPTOR BETA (31)
- ROR ALPHA (27)
- NR1D2 (24)
- PPAR DELTA (19)
- LXR ALPHA (17)
- NR2F6 (16)
- NR0B1 (14)
- VITAMIN D RECEPTOR (12)
- THYROID HORMONE RECEPTOR BETA (11)
- ARYL HYDROCARBON RECEPTOR (10)
- BILE ACID RECEPTOR (10)
- NR5A2 (10)
- PPAR GAMMA (10)
- LXR BETA (8)
- NUR77 (8)
- PXR (8)
- RETINOIC ACID RECEPTOR GAMMA (8)
- ASC1 (7)
- COUP TF1 (7)
- NR2F2 (7)
- RETINOIC ACID RECEPTOR BETA (7)
- RETINOID X RECEPTOR GAMMA (7)
- RETINOID X RECEPTOR ALPHA (6)
- RETINOID X RECEPTOR BETA (6)
- HNF4 GAMMA (4)
- NR2E1 (4)
- MED1 (3)
- MINERALOCORTICOID RECEPTOR (3)
- NURR1 (3)
- PGRMC1 (3)
- NR1D1 (2)
- PGRMC2 (2)
- PLAAT4 (2)
- NIF1 (1)
Reactivities
Antibody Hosts
Clonalities
Conjugates
Carrier-free
Knockout (KO) Validation
Modifications
Assay Types
Pathways
- Oocyte meiosis (208)
- Progesterone-mediated oocyte maturation (169)
- Pathways in cancer (141)
- Neuroactive ligand-receptor interaction (117)
- PPAR signaling pathway (107)
- Acute myeloid leukemia (66)
- Adipocytokine signaling pathway (61)
- Maturity onset diabetes of the young (52)
- Prostate cancer (39)
- Thyroid cancer (29)
- Non-small cell lung cancer (26)
- Small cell lung cancer (26)
- Wnt signaling pathway (19)
- Huntington's disease (10)
- MAPK signaling pathway (8)
- Circadian rhythm - mammal (2)